Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


340B Penny Pricing, Civil Monetary Penalty Revisions On Deck In Proposed Rule

Executive Summary

Proposed rule will revisit controversial provisions in the January 340B final rule to address manufacturer concerns about the US discount program.


Related Content

340B Drug Pricing, Penalties Need To Be Implemented, Congressional Leaders Say
Penny For Your Thoughts? HHS Secretary Azar’s Blunt Words For 340B Providers
340B Provider Reforms Gaining Momentum In Congress
HHS Regulatory Agenda Omits Drug Pricing Actions – Unless OTC Switches Still Count
Medicare Lowers Payments For 340B Drugs: Promising Sign For Further Reform?
A Penny Saved: Why Delaying 340B Pricing Rule Is Good News For Companies Like Horizon
340B ‘Penny Pricing’ Policy Formally Adopted By HHS; Overcharging Safe Harbors Created





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts